Product Name :
Bromo-PEG1-C2-Boc
Description:
Bromo-PEG1-C2-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
CAS:
1393330-36-3
Molecular Weight:
253.13
Formula:
C9H17BrO3
Chemical Name:
tert-butyl 3-(2-bromoethoxy)propanoate
Smiles :
CC(C)(C)OC(=O)CCOCCBr
InChiKey:
KRGOEVTUVNSLIG-UHFFFAOYSA-N
InChi :
InChI=1S/C9H17BrO3/c1-9(2,3)13-8(11)4-6-12-7-5-10/h4-7H2,1-3H3
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Bromo-PEG1-C2-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.|Product information|CAS Number: 1393330-36-3|Molecular Weight: 253.13|Formula: C9H17BrO3|Chemical Name: tert-butyl 3-(2-bromoethoxy)propanoate|Smiles: CC(C)(C)OC(=O)CCOCCBr|InChiKey: KRGOEVTUVNSLIG-UHFFFAOYSA-N|InChi: InChI=1S/C9H17BrO3/c1-9(2,3)13-8(11)4-6-12-7-5-10/h4-7H2,1-3H3|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.{{Mirin} site|{Mirin} ATM/ATR|{Mirin} Purity & Documentation|{Mirin} In stock|{Mirin} manufacturer|{Mirin} Cancer} |Shelf Life: ≥12 months if stored properly.{{Nimotuzumab} web|{Nimotuzumab} JAK/STAT Signaling|{Nimotuzumab} Protocol|{Nimotuzumab} Purity|{Nimotuzumab} manufacturer|{Nimotuzumab} Autophagy} |Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.PMID:23291014 |Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vitro:|PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.|Products are for research use only. Not for human use.|